Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Protara Therapeutics, Inc (TARA)  
$3.71 0.37 (11.08%) as of 4:30 Wed 5/15


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 10,510,000
Market Cap: 38.99(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.125 - $4.83
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Protara Therapeutics is a clinical-stage biopharmaceutical company focused on identifying and developing transformative therapies for the treatment of cancer and rare diseases. Co.'s primary oncology program is TARA-002 in non-muscle invasive bladder cancer. Co. is also pursuing TARA-002 in lymphatic malformations, which are rare, non-malignant cysts of the lymphatic vascular system. The third development program in Co.'s portfolio is intravenous Choline Chloride, an investigational phospholipid substrate replacement therapy initially in development for patients receiving parenteral nutrition, who have intestinal failure associated liver disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 42,965
Total Buy Value $0 $0 $0 $159,618
Total People Bought 0 0 0 3
Total Buy Transactions 0 0 0 4
Total Shares Sold 182,300 182,300 182,300 197,773
Total Sell Value $566,950 $566,950 $566,950 $608,899
Total People Sold 1 1 1 1
Total Sell Transactions 2 2 2 3
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 198
  Page 2 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Shefferman Jesse CEO and President   •       •      –    2023-01-10 4 D $3.00 $17,565 D/D (5,855) 866,982     -
   Bandari Jathin Chief Medical Officer   •       –      –    2023-01-10 4 D $3.00 $5,628 D/D (1,876) 18,442     -
   Zummo Jacqueline Chf Scientific Operations Off   •       –      –    2023-01-10 4 D $3.00 $15,675 D/D (5,225) 71,573     -
   Fry Hannah VP, Controller   •       –      –    2023-01-03 4 D $2.80 $1,011 D/D (361) 27,239     -
   Zummo Jacqueline Chf Scientific Operations Off   •       –      –    2023-01-03 4 D $2.80 $6,045 D/D (2,159) 76,798     -
   Shefferman Jesse CEO and President   •       •      –    2023-01-03 4 D $2.80 $18,491 D/D (6,604) 872,837     -
   Opaleye Management Inc. 10% Owner   –       –       •   2022-12-30 4 S $2.71 $41,949 I/I (15,473) 130,000 -26%     
   Opaleye Management Inc. 10% Owner   –       –       •   2022-09-15 4 B $3.80 $27,740 I/I 7,300 132,300 1.5 -20%     
   Opaleye Management Inc. 10% Owner   –       –       •   2022-09-14 4 B $3.98 $66,068 I/I 16,600 130,000 1.5 -20%     
   Shefferman Jesse CEO and President   •       •      –    2022-08-11 4 B $3.84 $34,810 D/D 9,065 879,441 2.81 -17%     
   Fry Hannah VP, Controller   •       –      –    2022-07-16 4 A $0.00 $0 D/D 25,000 27,600     -
   Davis Blaine Chief Financial Officer   •       –      –    2022-07-15 4 D $3.13 $15,904 D/D (5,081) 20,662     -
   Bandari Jathin Chief Medical Officer   •       –      –    2022-07-01 4 D $3.22 $2,196 D/D (682) 20,318     -
   Beshar Luke M Director   –       •      –    2022-06-30 4 B $3.10 $31,000 D/D 10,000 198,000 2.39 -17%     
   Opaleye Management Inc. 10% Owner   –       –       •   2022-04-08 4 B $4.80 $37,364 I/I 7,791 128 1.5 -36%     
   Opaleye Management Inc. 10% Owner   –       –       •   2022-04-07 4 B $4.74 $11,123 I/I 2,345 125,031 1.5 -25%     
   Beshar Luke M Director   –       •      –    2022-03-14 4 B $4.25 $42,500 D/D 10,000 188,000 2.39 -23%     
   Beshar Luke M Director   –       •      –    2022-03-10 4 B $4.46 $44,555 D/D 10,000 178,000 2.39 -32%     
   Opaleye Management Inc. 10% Owner   –       –       •   2022-01-28 4 B $4.96 $119,271 I/I 24,031 124,031 1.5 -31%     
   Bandari Jathin Chief Medical OfficerOfficer   •       –      –    2022-01-10 3 IO $0.00 $0 D/D 0 7,500 -50%     
   Zummo Jacqueline Chf Scientific Operations Off   •       –      –    2022-01-10 4 D $6.27 $28,861 D/D (4,603) 78,957     -
   Bandari Jathin Chief Medical Officer   •       –      –    2022-01-10 4 A $0.00 $0 D/D 13,500 13,500     -
   Shefferman Jesse CEO and President   •       •      –    2022-01-10 4 D $6.27 $31,852 D/D (5,080) 872,425     -
   Zummo Jacqueline Chf Scientific Operations Off   •       –      –    2022-01-03 4 A $0.00 $0 D/D 14,100 83,560     -
   Shefferman Jesse CEO and President   •       •      –    2022-01-03 4 A $0.00 $0 D/D 42,300 877,505     -
  198 Records found
  1  2  3  4  5  6  7  8   
  Page 2 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us